Clinical Trial Update: Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a third dose vaccination with AstraZeneca or Pfizer COVID-19 vaccine in adults who previously received Sinovac COVID-19 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection

Drugs mentioned

• AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19)
• Pfizer COVID-19 vaccine (tozinameran)

Snippet

Sponsor: Mahidol University | Conditions: COVID-19 Infection, COVID-19 VACCINE | Phase 2 | Status: COMPLETED